Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 17/20 | 0.62 |
| ▸ | ALB | P02768 | 2/20 | 0.62 |
| ▸ | BCL2 | P10415 | 4/20 | 0.48 |
| ▸ | PMAIP1 | Q13794 | 3/20 | 0.46 |
| ▸ | BAD | Q92934 | 4/20 | 0.45 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30000749 | 1.00 | MCL1 (0.62) | MCL1ALBBCL2PMAIP1BAD | |
| SCHEMBL24746695 | 0.89 | MCL1 (0.60) | MCL1ALBBCL2PMAIP1BAD | |
| SCHEMBL29999954 | 0.89 | MCL1 (0.66) | MCL1ALBBCL2PMAIP1BAD | |
| SCHEMBL24745228 | 0.89 | MCL1 (0.66) | MCL1ALBBCL2PMAIP1BAD | |
| SCHEMBL24745226 | 0.81 | MCL1 (0.52) | MCL1ALBBCL2 | |
| SCHEMBL30000975 | 0.81 | MCL1 (0.52) | MCL1ALBBCL2 | |
| SCHEMBL24745225 | 0.79 | MCL1 (0.55) | MCL1BCL2BCL2L1 | |
| SCHEMBL24745674 | 0.79 | MCL1 (0.56) | MCL1ALBBCL2PMAIP1 | |
| SCHEMBL24745273 | 0.78 | MCL1 (0.65) | MCL1ALBBCL2PMAIP1BAD | |
| SCHEMBL30000000 | 0.78 | MCL1 (0.65) | MCL1ALBBCL2PMAIP1BAD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022255888-A1 | TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN | CAPTOR THERAPEUTICS S.A. (PL) | 2022-12-08 | — | — | WO | disclosed |
| WO-2022253713-A1 | TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN | CAPTOR THERAPEUTICS S.A. (PL) | 2022-12-08 | — | — | WO | disclosed |